Spero Therapeutics Inc (SPRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SPRO | FATE | VOR | ||
| Company | Spero Therapeutics Inc | Fate Therapeutics | Vor Biopharma Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.36 | 1.1200 | 12.00 | ||
| High | 2.36 | 1.1650 | 14.13 | ||
| Low | 2.30 | 1.0900 | 11.77 | ||
| Latest | 2.32 | 1.1500 | 12.51 | ||
| Change | -0.03 | +0.0400 | +0.38 | ||
| % Change | -1.28% | +3.60% | +3.13% | ||
| Volume | 287,700 | 1,407,600 | 3,396,600 | ||
| 20-Day Average Volume | 343,190 | 1,219,535 | 3,069,880 | ||
| Previous Close | 2.35 | 1.1100 | 12.13 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.33 | 1.0591 | 8.91 | ||
| 20-Day Raw Stochastic | 35.90% | 93.02% | 78.77% | ||
| 20-Day Relative Strength | 50.12 | 51.11 | 43.35 | ||
| Weighted Alpha | -19.28 | -50.44 | -69.07 | ||
| Today's Opinion | 40% Buy | 8% Sell | 72% Sell | ||
| Previous Opinion | 88% Buy | 24% Sell | 72% Sell | ||
| Last Month's Opinion | 88% Buy | 8% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.65% since 12/05/25 | +6.48% since 12/05/25 | +52.93% since 12/05/25 | ||
| Low | 2.26 on 12/09/25 | 1.0300 on 12/08/25 | 7.99 on 12/08/25 | ||
| High | 2.39 on 12/10/25 | 1.1650 on 12/12/25 | 14.13 on 12/12/25 | ||
| 1-Month | |||||
| %Chg | -12.78% since 11/12/25 | +10.58% since 11/12/25 | +24.35% since 11/12/25 | ||
| Low | 2.18 on 12/03/25 | 0.9500 on 11/14/25 | 6.50 on 11/20/25 | ||
| High | 2.72 on 11/13/25 | 1.1650 on 12/12/25 | 14.13 on 12/12/25 | ||
| 3-Month | |||||
| %Chg | +22.11% since 09/12/25 | +19.41% since 09/12/25 | -64.05% since 09/12/25 | ||
| Low | 1.84 on 09/30/25 | 0.9401 on 09/15/25 | 6.50 on 11/20/25 | ||
| High | 2.75 on 11/12/25 | 1.9399 on 10/27/25 | 49.95 on 09/30/25 | ||
| 6-Month | |||||
| %Chg | -19.72% since 06/12/25 | -17.86% since 06/12/25 | +197.86% since 06/12/25 | ||
| Low | 1.80 on 08/20/25 | 0.9100 on 08/11/25 | 3.63 on 06/13/25 | ||
| High | 3.22 on 07/09/25 | 1.9399 on 10/27/25 | 65.80 on 07/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 130,706 | 132,655 | 130,242 | ||
| Shares Outstanding, K | 56,339 | 115,352 | 10,411 | ||
| Annual Sales | 47,980,000 | 13,630,000 | 0 | ||
| Annual Net Income | -68,570,000 | -186,260,000 | -116,914,000 | ||
| Last Quarter Sales | 5,440,000 | 1,740,000 | 0 | ||
| Last Quarter Net Income | -7,380,000 | -32,250,000 | -812,684,000 | ||
| 60-Month Beta | 1.48 | 2.34 | 2.08 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.13 on 11/13/25 | -0.27 on 11/13/25 | -3.33 on 11/13/25 | ||
| Latest Earnings Date | 03/26/26 | 03/04/26 | 03/19/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | 09/16/15 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||